Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Psychedelics Business

Novamind Adding 4 Psychedelic Mental Health Clinics, Doubling Size of Network
05/04/2021
Novamind, a mental health company that specializes in psychedelic medicine, has announced plans to open 4 new Cedar Psychiatry clinics in Utah, which will double its network to 8 locations in the state overall. Construction has begun on...
Novamind, a mental health company that specializes in psychedelic medicine, has announced plans to open 4 new Cedar Psychiatry clinics in Utah, which will double its network to 8 locations in the state overall. Construction has begun on...
Novamind, a mental health...
05/04/2021
Behavioral Healthcare Executive
Field Trip Health Opens Houston Center, Plans 5 More Facilities
05/04/2021
Psychedelic therapy provider Field Trip Health on Tuesday announced the opening of its fifth U.S. location, along with plans to build five more locations. The newly opened location is in the River Oaks District of Houston and is Field Trip’s...
Psychedelic therapy provider Field Trip Health on Tuesday announced the opening of its fifth U.S. location, along with plans to build five more locations. The newly opened location is in the River Oaks District of Houston and is Field Trip’s...
Psychedelic therapy provider...
05/04/2021
Behavioral Healthcare Executive
MindMed Begins Trading on Nasdaq
04/28/2021
MindMed, a psychedelic medicine biotech firm, is now on the Nasdaq Capital Market. Trading of MindMed shares began on Tuesday under the symbol “MNMD.” The company also trades on the Canadian exchange NEO (symbol: MMED) and in Germany...
MindMed, a psychedelic medicine biotech firm, is now on the Nasdaq Capital Market. Trading of MindMed shares began on Tuesday under the symbol “MNMD.” The company also trades on the Canadian exchange NEO (symbol: MMED) and in Germany...
MindMed, a psychedelic medicine...
04/28/2021
Behavioral Healthcare Executive
Adoption of Psychedelic-Assisted Therapy Shows Path for Other Practices
Adoption of Psychedelic-Assisted Therapy Shows Path for Other Practices
04/12/2021
We should study psychedelic-assisted therapy apart from its potential clinical value. It offers important lessons on the adoption of healthcare practices. Scientific progress often follows a circuitous path, but the journey taken by this...
We should study psychedelic-assisted therapy apart from its potential clinical value. It offers important lessons on the adoption of healthcare practices. Scientific progress often follows a circuitous path, but the journey taken by this...
We should study...
04/12/2021
Behavioral Healthcare Executive
News
Mass General Opens Center to Study Psychedelics in Treatment of Mental Illness
03/15/2021
Massachusetts General Hospital recently announced the opening of a new program to study the use of psychedelics to treat mental illnesses, including depression, anxiety and PTSD.
Massachusetts General Hospital recently announced the opening of a new program to study the use of psychedelics to treat mental illnesses, including depression, anxiety and PTSD.
Massachusetts General Hospital...
03/15/2021
Behavioral Healthcare Executive
Aion Therapeutic Opens International Center in Jamaica
03/04/2021
Aion Therapeutic has announced the opening of the Aion International Center for Psychedelic Psychiatry, a Jamaica-based facility that will specialize in the use of psilocybin in treating addiction, depression, major depressive disorder, and...
Aion Therapeutic has announced the opening of the Aion International Center for Psychedelic Psychiatry, a Jamaica-based facility that will specialize in the use of psilocybin in treating addiction, depression, major depressive disorder, and...
Aion Therapeutic has announced...
03/04/2021
Behavioral Healthcare Executive
atai Life Sciences Announces Close of $157 Million Financing Round
03/03/2021
atai Life Sciences, a biopharmaceutical firm developing psychedelic and non-psychedelic compounds for mental health disorders, announced on Wednesday that it has closed a $157 million Series D round of financing. The company has been valued...
atai Life Sciences, a biopharmaceutical firm developing psychedelic and non-psychedelic compounds for mental health disorders, announced on Wednesday that it has closed a $157 million Series D round of financing. The company has been valued...
atai Life Sciences, a...
03/03/2021
Behavioral Healthcare Executive
ATMA Opens Psychedelic Therapy Facility in Calgary
02/22/2021
ATMA Journey Centers this month has opened the first non-ketamine psychedelic therapy clinic in Canada. The Alberta-based company announced the opening of ATMA Calgary Urban Journey Clinic, a 5,000-square-foot facility in central Calgary...
ATMA Journey Centers this month has opened the first non-ketamine psychedelic therapy clinic in Canada. The Alberta-based company announced the opening of ATMA Calgary Urban Journey Clinic, a 5,000-square-foot facility in central Calgary...
ATMA Journey Centers this month...
02/22/2021
Behavioral Healthcare Executive
News
Field Trip Opens Treatment Center in Atlanta
01/27/2021
Field Trip Health this week announced the opening of a new location in Atlanta. The facility joins Field Trip’s other U.S. sites in New York, Los Angeles and Chicago, and it is the first of several new treatment centers the company plans to...
Field Trip Health this week announced the opening of a new location in Atlanta. The facility joins Field Trip’s other U.S. sites in New York, Los Angeles and Chicago, and it is the first of several new treatment centers the company plans to...
Field Trip Health this week...
01/27/2021
Behavioral Healthcare Executive
News
Former NHL Player Launches Psychedelics Company
01/25/2021
Former NHL player Daniel Carcillo has founded Wesana Health, an emerging life sciences company that will focus on developing psychedelic-assisted therapies to treat traumatic brain injuries.
Former NHL player Daniel Carcillo has founded Wesana Health, an emerging life sciences company that will focus on developing psychedelic-assisted therapies to treat traumatic brain injuries.
Former NHL player Daniel...
01/25/2021
Behavioral Healthcare Executive

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement